CHINA MEDICAL SYSTEM HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.06 HKD | +0.14% |
|
-3.02% | -48.99% |
| Sales 2024 * | 7.99B 1.1B 8.65B | Sales 2025 * | 9.59B 1.32B 10.37B | Capitalization | 15.9B 2.2B 17.21B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.77B 244M 1.91B | Net income 2025 * | 2.61B 361M 2.83B | EV / Sales 2024 * | 1.57 x |
| Net cash position 2024 * | 3.34B 461M 3.61B | Net cash position 2025 * | 3.79B 524M 4.1B | EV / Sales 2025 * | 1.26 x |
| P/E ratio 2024 * |
9.17
x | P/E ratio 2025 * |
6.53
x | Employees | 5,701 |
| Yield 2024 * |
4.83% | Yield 2025 * |
5.25% | Free-Float | 50.45% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.14% | ||
| 1 week | -3.02% | ||
| Current month | -14.11% | ||
| 1 month | -43.43% | ||
| 3 months | -41.46% | ||
| 6 months | -40.17% | ||
| Current year | -48.99% |
1 week
6.87
7.38
1 month
6.8712.74
Current year
6.8713.98
1 year
6.8715.86
3 years
6.8722.80
5 years
6.1422.80
10 years
6.1422.80
| Managers | Title | Age | Since |
|---|---|---|---|
Kong Lam
CEO | Chief Executive Officer | 59 | 94-12-31 |
Yan Ling Chen
DFI | Director of Finance/CFO | 54 | 94-12-31 |
Wai Ming Wong
CTO | Chief Tech/Sci/R&D Officer | 64 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Bing Chen
COO | Chief Operating Officer | 57 | 94-12-31 |
Ching Fung
BRD | Director/Board Member | 55 | 21-10-05 |
Ying Luo
BRD | Director/Board Member | 59 | 20-03-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.82% | 4 M€ | -27.92% | ||
| 0.84% | 2 M€ | -20.08% | - | |
| 0.44% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 7.06 | +0.14% | 13 314 010 |
| 24-04-17 | 7.05 | -1.12% | 14,148,500 |
| 24-04-16 | 7.13 | -0.28% | 10,840,190 |
| 24-04-15 | 7.15 | -1.38% | 12,489,210 |
| 24-04-12 | 7.25 | -0.41% | 9,827,727 |
Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT
More quotes
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
6.517
CNY
Average target price
11.42
CNY
Spread / Average Target
+75.27%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -48.99% | 2.2B | |
| +28.79% | 676B | |
| +24.82% | 554B | |
| -7.64% | 349B | |
| +15.00% | 318B | |
| +5.99% | 291B | |
| +3.34% | 210B | |
| -0.19% | 204B | |
| -9.69% | 194B | |
| -11.71% | 144B |
- Stock Market
- Equities
- 867 Stock
